CSAM announces first day of trading on Merkur Market
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN
CSAM Health Group AS (CSAM), the leading provider of niche eHealth solutions in the Nordics, today began trading on Merkur Market under the ticker symbol CSAM-ME.
More information can be found at CSAM’s website.
For further information, please contact
Louise Nilsson is Partner and CEO. In addition to leading and developing Priveq, she is responsible for sourcing new investment opportunities, in which Priveq will contribute with growth and value creation as well as implement growth strategies in cooperation with other owners, the board and management.
Since Louise joined Priveq in 1998, she has, among others, been responsible for the ownership in Carmel Pharma, Hemtex, Swedish Orphan International and Vårdapoteket. She is currently a Director of the Boards in 21 Grams, CSAM Health, Metenova, Plint and Ports Group.
Prior to Priveq, Louise worked as chartered accountant for ÖhrlingsCoopers & Lybrand (current PwC) for nine years, with responsibility for small and medium-sized owner-led companies.
Louise holds a B.Sc. in Business Administration from Luleå University.